Abstract
Four structurally different Cd-Ln heteronuclear complexes based on the linear chain ether Schiff base ligand (bis(3-methoxysalicylidene)-3-oxapentane-1,5-diamine (H2L) and the co-ligands 4,4′-bipyridine (bipy) or isonicotinate (IN), with composition [PrCd2L2(CH3COO)2](NO3)·CH2Cl2 (1), {[SmCdL(bipy)(NO3)3]·CH2Cl2·CH3CH2OH}n (2), [YbCdL(IN)(NO3)(CH3COO)]n (3) and {[Nd2Cd2L2(IN)2(NO3)2(CH3OH)2(CH3COO)](NO3)}n (4), have been synthesized by interfacial diffusion methods. Structural regulation is achieved by changes in the co-ligands or Ln(III) ions of different radii: Single crystal X-ray analysis determined that 1 is a trinuclear cluster with the Pr(III) ion as a joint bridging of two CdL coordination units; 2 and 3 are both infinite one-dimensional zigzag coordination polymers consisting of CdLnL secondary units through coordination bridging bipy or IN; 4 is a two-dimensional graphene laminate structure formed by two types of CdNdL secondary units bridged by both IN and acetate simultaneously. In the solid state, the complexes 1–4 all exhibit fluorescence peaks based on H2L with blue shift and enhancement. The order of fluorescence peaks intensity of the complexes in N,N-dimethylformamide (DMF) solution is consistent with that in the solid state. Moreover, the corresponding characteristic emissions of Sm(III) ion in complex 2 can be observed in the fluorescence spectra in either solid state and DMF solution, indicating that [CdL] unit is suitable for the sensitization of Sm(III) ion.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.